We are live on ! Find out more
ABLA

Alan B. Lancz & Associates Portfolio holdings

AUM $103M
1-Year Est. Return 31.99%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+31.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99M
AUM Growth
+$14.8M
Cap. Flow
+$4.01M
Cap. Flow %
4.05%
Top 10 Hldgs %
28.82%
Holding
191
New
32
Increased
11
Reduced
32
Closed
4

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$339K
2
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
+$300K
3
GNRC icon
Generac Holdings
GNRC
+$255K
4
MDT icon
Medtronic
MDT
+$239K
5
SHOP icon
Shopify
SHOP
+$200K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$681K
2
EA
Electronic Arts
EA
+$220K
3
WBD icon
Warner Bros
WBD
+$177K
4
ST icon
Sensata Technologies
ST
+$138K
5
NWL icon
Newell Brands
NWL
+$133K

Sector Composition

Rank Sector Weight
1 Technology 18.72%
2 Healthcare 14.87%
3 Communication Services 10.69%
4 Financials 10.13%
5 Industrials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
176
Visa
V
$677B
$134K 0.14%
+600
New +$121K
DELL icon
177
Dell
DELL
$293B
$133K 0.13%
+3,308
New +$131K
OGS icon
178
ONE Gas
OGS
$5.04B
$133K 0.13%
+1,650
New +$127K
WFC icon
179
Wells Fargo
WFC
$264B
$133K 0.13%
+3,000
New +$133K
EMN icon
180
Eastman Chemical
EMN
$8.42B
$133K 0.13%
+1,450
New +$117K
ZBH icon
181
Zimmer Biomet
ZBH
$18.4B
$130K 0.13%
+1,050
New +$122K
TDS icon
182
Telephone and Data Systems
TDS
$3.75B
$127K 0.13%
11,147
-109
-1% -$1.35K
GLW icon
183
Corning
GLW
$143B
$126K 0.13%
+3,506
New +$114K
EA
184
DELISTED
Electronic Arts
EA
-1,900
Closed -$220K
NWL icon
185
Newell Brands
NWL
$2.56B
-9,550
Closed -$133K
ST icon
186
Sensata Technologies
ST
$6.79B
-3,700
Closed -$138K
WBD icon
187
Warner Bros
WBD
$67.1B
-15,352
Closed -$177K

Similar funds

Alan B. Lancz & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Alan B. Lancz & Associates held 191 positions worth $99M, up 18% from $84.3M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Alan B. Lancz & Associates deployed $4.01M of net new capital in Q4 2022, opening 32 new positions and adding to 11 existing holdings. Its largest new stake was GSK: 10,180 shares worth $360K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was 3M, an estimated $681K trimmed.

  • Alan B. Lancz & Associates's largest Q4 2022 buy was GSK: 10,180 shares worth $360K.
  • Alan B. Lancz & Associates added most to Medtronic in Q4 2022, an estimated $239K increase.
  • Alan B. Lancz & Associates's biggest Q4 2022 reduction was 3M, cutting an estimated $681K.
  • Alan B. Lancz & Associates fully exited Electronic Arts in Q4 2022, selling an estimated $220K.
  • Alan B. Lancz & Associates's ten largest holdings make up 29% of its $99M portfolio in Q4 2022.
  • Alan B. Lancz & Associates opened 32 new positions and closed 4 in Q4 2022.
  • Alan B. Lancz & Associates's portfolio value rose 18% quarter-over-quarter to $99M.

Based on Alan B. Lancz & Associates's 13F filing for Q4 2022, filed 13 Feb 2023.